BACKGROUND: Although many genetic epidemiology and biomarker studies have been conducted to examine associations of genetic variants and circulating proteins with cardiovascular disease and risk factors, there has been little study of gene expression or transcriptomics. Quantitative differences in the abundance of transcripts has been demonstrated in malignancies, but gene expression from a large community-based cohort examining risk of cardiovascular disease has never been reported. METHODS AND RESULTS: On the basis of preliminary microarray data and previously suggested genes from the literature, we measured expression of 48 genes by high-throughput quantitative reverse-transcriptase polymerase chain reaction in 1846 participants of the Framingham Offspring cohort from RNA derived from isolated platelets and leukocytes. A multivariable stepwise regression model was used to assess clinical correlates of quantitative RNA expression. For specific inflammatory platelet-derived transcripts, including ICAM1, IFNG, IL1R1, IL6, MPO, COX2, TNF, TLR2, and TLR4, there were significant associations with higher body mass index (BMI). Compared with platelets, fewer leukocyte-derived transcripts were associated with BMI or other cardiovascular risk factors. Select transcripts were found to be highly heritable, including GPIBA and COX1. Almost uniformly, heritable transcripts were not those associated with BMI. CONCLUSIONS: Inflammatory transcripts derived from platelets, particularly those part of the nuclear factor kappa B pathway, are associated with BMI, whereas others are heritable. This is the first study, using a large community-based cohort, to demonstrate clinical correlates of gene expression and is consistent with the hypothesis that specific peripheral-blood transcripts play a role in the pathogenesis of coronary heart disease and its risk factors.
BACKGROUND: Although many genetic epidemiology and biomarker studies have been conducted to examine associations of genetic variants and circulating proteins with cardiovascular disease and risk factors, there has been little study of gene expression or transcriptomics. Quantitative differences in the abundance of transcripts has been demonstrated in malignancies, but gene expression from a large community-based cohort examining risk of cardiovascular disease has never been reported. METHODS AND RESULTS: On the basis of preliminary microarray data and previously suggested genes from the literature, we measured expression of 48 genes by high-throughput quantitative reverse-transcriptase polymerase chain reaction in 1846 participants of the Framingham Offspring cohort from RNA derived from isolated platelets and leukocytes. A multivariable stepwise regression model was used to assess clinical correlates of quantitative RNA expression. For specific inflammatory platelet-derived transcripts, including ICAM1, IFNG, IL1R1, IL6, MPO, COX2, TNF, TLR2, and TLR4, there were significant associations with higher body mass index (BMI). Compared with platelets, fewer leukocyte-derived transcripts were associated with BMI or other cardiovascular risk factors. Select transcripts were found to be highly heritable, including GPIBA and COX1. Almost uniformly, heritable transcripts were not those associated with BMI. CONCLUSIONS: Inflammatory transcripts derived from platelets, particularly those part of the nuclear factor kappa B pathway, are associated with BMI, whereas others are heritable. This is the first study, using a large community-based cohort, to demonstrate clinical correlates of gene expression and is consistent with the hypothesis that specific peripheral-blood transcripts play a role in the pathogenesis of coronary heart disease and its risk factors.
Authors: Clive S Zent; Fenghuang Zhan; Steven A Schichman; Klaus H W Bumm; Pei Lin; James B Chen; John D Shaughnessy Journal: Leuk Res Date: 2003-09 Impact factor: 3.156
Authors: Jerald P Radich; Mao Mao; Sergey Stepaniants; Matt Biery; John Castle; Terry Ward; Greg Schimmack; Sumire Kobayashi; Michael Carleton; Johanna Lampe; Peter S Linsley Journal: Genomics Date: 2004-06 Impact factor: 5.736
Authors: K J Martin; E Graner; Y Li; L M Price; B M Kritzman; M V Fournier; E Rhei; A B Pardee Journal: Proc Natl Acad Sci U S A Date: 2001-02-20 Impact factor: 11.205
Authors: Peter J Armstrong; Jason M Johanning; William C Calton; Jason R Delatore; David P Franklin; David C Han; David J Carey; James R Elmore Journal: J Vasc Surg Date: 2002-02 Impact factor: 4.268
Authors: Adeline R Whitney; Maximilian Diehn; Stephen J Popper; Ash A Alizadeh; Jennifer C Boldrick; David A Relman; Patrick O Brown Journal: Proc Natl Acad Sci U S A Date: 2003-02-10 Impact factor: 11.205
Authors: Xiaoling Zhang; Andrew D Johnson; Audrey E Hendricks; Shih-Jen Hwang; Kahraman Tanriverdi; Santhi K Ganesh; Nicholas L Smith; Patricia A Peyser; Jane E Freedman; Christopher J O'Donnell Journal: Hum Mol Genet Date: 2013-09-20 Impact factor: 6.150
Authors: Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman Journal: Semin Immunopathol Date: 2011-08-06 Impact factor: 9.623
Authors: Lea M Beaulieu; Elaine Lin; Eric Mick; Milka Koupenova; Ellen O Weinberg; Carolyn D Kramer; Caroline A Genco; Kahraman Tanriverdi; Martin G Larson; Emelia J Benjamin; Jane E Freedman Journal: Arterioscler Thromb Vasc Biol Date: 2014-01-23 Impact factor: 8.311
Authors: Lukas M Simon; Leonard C Edelstein; Srikanth Nagalla; Angela B Woodley; Edward S Chen; Xianguo Kong; Lin Ma; Paolo Fortina; Satya Kunapuli; Michael Holinstat; Steven E McKenzie; Jing-Fei Dong; Chad A Shaw; Paul F Bray Journal: Blood Date: 2014-02-12 Impact factor: 22.113
Authors: Roby Joehanes; Saixia Ying; Tianxiao Huan; Andrew D Johnson; Nalini Raghavachari; Richard Wang; Poching Liu; Kimberly A Woodhouse; Shurjo K Sen; Kahraman Tanriverdi; Paul Courchesne; Jane E Freedman; Christopher J O'Donnell; Daniel Levy; Peter J Munson Journal: Arterioscler Thromb Vasc Biol Date: 2013-03-28 Impact factor: 8.311